ARQT

26.3602.98%
TJ

Terrie J. Curran

Independent Director

Ms. Terrie J. Curran was a Director of Phathom Pharmaceuticals, Inc. since August 2019 until April 1, 2025 and served as its Chief Executive Officer since December 02, 2019 until April 1, 2025 and also served as its President until April 1, 2025. Ms. Curran serves as an Independent Director at Arcutis Biotherapeutics, Inc. since November 02, 2020. Ms. Curran served as the President of Global Inflammation & Immunology at Celgene Corporation since April 1, 2017. Ms. Curran had been a Corporate Vice President USA with Celgene Pharmaceuticals since 2013. She served as Head of Worldwide Commercial Markets for Global Inflammation & Immunology (I&I) Franchise at Celgene Corporation since 2016 until April 1, 2017. She served as President of Global Inflammation and Immunology Franchise of Celgene Corporation since April 2017 until September 2019. Ms. Curran joined Celgene in 2013 as the U.S. Commercial Head of the I&I Franchise and built the capabilities and recruited the teams that executed the successful launch of OTEZLA, before becoming Head of Worldwide Markets. She served as Senior Vice President and General Manager of Global Women?s Health business at Merck and Co., Inc. Before Merck, she served as a General Manager of Australia and New Zealand of Schering-Plough Corp. She has comprehensive experience from the pharmaceutical industry from her executive roles with, inter alia, Merck and Celgene with responsibilities in sales, marketing and market access as well as licensing, alliance management, pipeline and portfolio management. Ms. Curran has held global commercial and marketing leadership roles. Her special qualifications include strong global commercial experience and knowledge, including the US market. Her knowledge serves her as a Discussion Partner for the Board and Executive Management. She had been an Independent Director of Myovant Sciences Ltd. since November 2016 until March 2023. She served as a Director of BioNJ Inc. since 2018 until June 2018. She served as a Director of H. Lundbeck A/S since March 2014 until March 2017. Ms. Curran holds BSc in Applied Sciences and Graduate Diploma of Marketing from the University of Technology in Sydney.

Positions